The Latest Cardiac and Vascular News
The objective of this study is to obtain data on the technical feasibility, safety, and efficacy of the second-generation eCLIPs products for the treatment of bifurcation aneurysms. VANCOUVER, British Columbia–(BUSINESS WIRE)–Evasc Neurovascular, a pioneer in the development of disruptive endovascular […]
VANCOUVER, British Columbia–(BUSINESS WIRE)–Evasc Neurovascular is proud to announce the third generation of its eCLIPs™ device, the eCLIPs Bifurcation Flow Diverter. The new device is classified as a flow diverter, with a leaf density of 35%, which is 60% higher […]
VANCOUVER, June 15, 2017 /PRNewswire/ – Evasc Neurovascular Enterprises ULC announced that it has closed a CAD $10 million Series A venture capital financing round, led by Yonghua Investment Management Co., Ltd. (“Yonghua Capital”) of Shanghai, China. Several of Evasc’s […]
